These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9269877)

  • 1. Determination of the optical purity of ibuprofen using X-ray powder diffraction.
    Stahly GP; McKenzie AT; Andres MC; Russell CA; Byrn SR; Johnson P
    J Pharm Sci; 1997 Aug; 86(8):970-1. PubMed ID: 9269877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigation of structural characteristics of initial substances of ibuprofen and micronization impact].
    Lobanov NN; Khuchua NS; Obidchenko IuA; Abramovich RA
    Antibiot Khimioter; 2012; 57(3-4):3-8. PubMed ID: 22993933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ab initio structure determination of phase II of racemic ibuprofen by X-ray powder diffraction.
    Derollez P; Dudognon E; Affouard F; Danède F; Correia NT; Descamps M
    Acta Crystallogr B; 2010 Feb; 66(Pt 1):76-80. PubMed ID: 20101086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantification of an enantiomer and the racemic compound of ibuprofen by X-ray powder diffractometry.
    Phadnis NV; Suryanarayanan R
    Pharm Res; 1997 Sep; 14(9):1176-80. PubMed ID: 9327444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of enantiomers of ibuprofen by liquid chromatography: a review.
    Bhushan R; Martens J
    Biomed Chromatogr; 1998; 12(6):309-16. PubMed ID: 9861488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.
    Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS
    Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative determination of polymorphs of indomethacin in powders and tablets by chemometrical near-infrared spectroscopy and x-ray powder diffractometry.
    Otsuka M; Kato F; Matsuda Y; Ozaki Y
    AAPS PharmSciTech; 2003; 4(2):E19. PubMed ID: 12916901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical stability of solid dispersions of enantiomeric or racemic ibuprofen in stearic acid.
    Corvis Y; Négrier P; Espeau P
    J Pharm Sci; 2011 Dec; 100(12):5235-43. PubMed ID: 21905027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of (+/-)-ibuprofen using (-)-brucine as a chiral selector by thin layer chromatography.
    Bhushan R; Gupta D
    Biomed Chromatogr; 2004 Dec; 18(10):838-40. PubMed ID: 15386571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separatory determination of diastereomeric ibuprofen glucuronides in human urine by liquid chromatography/electrospray ionization-mass spectrometry.
    Ikegawa S; Murao N; Oohashi J; Goto J
    Biomed Chromatogr; 1998; 12(6):317-21. PubMed ID: 9861489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical aspects of dexibuprofen and racemic ibuprofen.
    Leising G; Resel R; Stelzer F; Tasch S; Lanziner A; Hantich G
    J Clin Pharmacol; 1996 Dec; 36(12 Suppl):3S-6S. PubMed ID: 9013377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral discrimination in the transport of ketoprofen and ibuprofen esters through an aqueous phase mediated by various serum albumins.
    Nakagawa H; Shimizu K; Yamada K
    Chirality; 1999; 11(5-6):516-9. PubMed ID: 10368926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a new crystalline phase of racemic Ibuprofen.
    Dudognon E; Danède F; Descamps M; Correia NT
    Pharm Res; 2008 Dec; 25(12):2853-8. PubMed ID: 18563538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions during aqueous film coating of ibuprofen with aquacoat ECD.
    Schmid S; Müller-Goymann CC; Schmidt PC
    Int J Pharm; 2000 Mar; 197(1-2):35-9. PubMed ID: 10704791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
    Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
    Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.